Home > Healthcare > Pharmaceuticals > Finished Drug Form > Blood Platelets Market
The growing demand for blood transfusions has stimulated the industry revenue. This significant upsurge in blood transfusion demand is owing to the rising rate of approval by the U.S. FDA for blood transfusion products comprising blood platelets, the advent of novel technologies that are assisting in blood donation & storage, etc. The increasing prevalence of blood diseases is among the key factors driving the demand for blood transfusion.
Further, blood centers are also keeping meticulous records, managing highly regulated manufacturing practices, supporting & participating in various clinical trials, and expanding to new product lines & therapies. The lessened risk of catching a virus or any other blood-borne disease from a blood transfusion will further stimulate the adoption of blood platelets, thereby augmenting the market share.